Current strategies for the prevention of breast cancer

Pooja Advani, Alvaro Moreno-AspitiaDepartment of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, USAAbstract: Due to the high incidence of breast cancer in the United States, optimal strategies for its prevention are imperative. This entails identification of women who are at an increased r...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Advani P, Moreno-Aspitia A
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2014
Materias:
Acceso en línea:https://doaj.org/article/3becfb1bd2734756aa3e3d9a5794d2c5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3becfb1bd2734756aa3e3d9a5794d2c5
record_format dspace
spelling oai:doaj.org-article:3becfb1bd2734756aa3e3d9a5794d2c52021-12-02T02:15:26ZCurrent strategies for the prevention of breast cancer1179-1314https://doaj.org/article/3becfb1bd2734756aa3e3d9a5794d2c52014-05-01T00:00:00Zhttp://www.dovepress.com/current-strategies-for-the-prevention-of-breast-cancer-a16662https://doaj.org/toc/1179-1314 Pooja Advani, Alvaro Moreno-AspitiaDepartment of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, USAAbstract: Due to the high incidence of breast cancer in the United States, optimal strategies for its prevention are imperative. This entails identification of women who are at an increased risk for breast cancer and an integrative approach that includes effective screening methods as well as nutritional, pharmacologic, and surgical management. Several breast cancer risk-assessment tools, such as the Gail and Claus models, can help clinicians determine the quantitative risk of breast cancer. The role of selective estrogen receptor modulators, such as tamoxifen and raloxifene, for the prevention of breast cancer has been well established. Several other agents, such as aromatase inhibitors, are currently being investigated. The potential adverse effects of these chemopreventive agents, which include an impact on the quality of life, must be discussed with the patient before deciding on this approach. Additionally, breast cancer risk factors have been identified over the years; some of them are modifiable, but others are not. Although there is no conclusive evidence to suggest the protective role of specific dietary components, alcohol consumption and obesity are associated with an increased breast cancer risk; thus lifestyle changes can lead to a lower risk of developing breast cancer. Surgical approaches, including bilateral risk-reduction mastectomy and salpingo-oophorectomy, are usually limited to women with a hereditary predisposition to development of breast cancer. The objective of this review is to summarize the various approaches directed at reducing the incidence of breast cancer.Keywords: chemoprevention, tamoxifen, raloxifene, prophylactic surgeryAdvani PMoreno-Aspitia ADove Medical PressarticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENBreast Cancer: Targets and Therapy, Vol 2014, Iss default, Pp 59-71 (2014)
institution DOAJ
collection DOAJ
language EN
topic Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Advani P
Moreno-Aspitia A
Current strategies for the prevention of breast cancer
description Pooja Advani, Alvaro Moreno-AspitiaDepartment of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, USAAbstract: Due to the high incidence of breast cancer in the United States, optimal strategies for its prevention are imperative. This entails identification of women who are at an increased risk for breast cancer and an integrative approach that includes effective screening methods as well as nutritional, pharmacologic, and surgical management. Several breast cancer risk-assessment tools, such as the Gail and Claus models, can help clinicians determine the quantitative risk of breast cancer. The role of selective estrogen receptor modulators, such as tamoxifen and raloxifene, for the prevention of breast cancer has been well established. Several other agents, such as aromatase inhibitors, are currently being investigated. The potential adverse effects of these chemopreventive agents, which include an impact on the quality of life, must be discussed with the patient before deciding on this approach. Additionally, breast cancer risk factors have been identified over the years; some of them are modifiable, but others are not. Although there is no conclusive evidence to suggest the protective role of specific dietary components, alcohol consumption and obesity are associated with an increased breast cancer risk; thus lifestyle changes can lead to a lower risk of developing breast cancer. Surgical approaches, including bilateral risk-reduction mastectomy and salpingo-oophorectomy, are usually limited to women with a hereditary predisposition to development of breast cancer. The objective of this review is to summarize the various approaches directed at reducing the incidence of breast cancer.Keywords: chemoprevention, tamoxifen, raloxifene, prophylactic surgery
format article
author Advani P
Moreno-Aspitia A
author_facet Advani P
Moreno-Aspitia A
author_sort Advani P
title Current strategies for the prevention of breast cancer
title_short Current strategies for the prevention of breast cancer
title_full Current strategies for the prevention of breast cancer
title_fullStr Current strategies for the prevention of breast cancer
title_full_unstemmed Current strategies for the prevention of breast cancer
title_sort current strategies for the prevention of breast cancer
publisher Dove Medical Press
publishDate 2014
url https://doaj.org/article/3becfb1bd2734756aa3e3d9a5794d2c5
work_keys_str_mv AT advanip currentstrategiesforthepreventionofbreastcancer
AT morenoaspitiaa currentstrategiesforthepreventionofbreastcancer
_version_ 1718402585564545024